Fluoroquinolones are a class of prescription antibiotics used to treat serious bacterial infections. They work by blocking two enzymes bacteria need to copy their DNA, which kills the bacteria rather than simply slowing their growth. Ciprofloxacin, levofloxacin, moxifloxacin, and delafloxacin are the most commonly prescribed members of this class. While effective against a wide range of bacteria, fluoroquinolones carry a boxed warning from the FDA (the most serious warning a drug can receive) due to rare but potentially permanent side effects involving tendons, nerves, and the central nervous system.
How Fluoroquinolones Work
Bacteria rely on two enzymes, DNA gyrase and topoisomerase IV, to unwind and replicate their DNA. Fluoroquinolones bind to these enzymes and block them, which stops bacterial DNA from copying itself. Without functioning DNA replication, the bacteria die. This makes fluoroquinolones bactericidal, meaning they actively kill bacteria rather than just preventing them from multiplying.
Because they target enzymes found in many types of bacteria, fluoroquinolones are considered broad-spectrum antibiotics. They can treat infections caused by both gram-positive and gram-negative bacteria, which is why doctors sometimes turn to them for complicated or hard-to-treat infections.
When They’re Prescribed
Fluoroquinolones are generally reserved for more serious infections. The FDA and other regulatory agencies have recommended against using them for uncomplicated conditions like sinus infections, simple urinary tract infections, or acute bronchitis. For those conditions, safer alternatives with fewer risks are usually available.
Where fluoroquinolones still play an important role is in treating infections where other antibiotics may not work well or where the infection is severe. These include certain types of pneumonia, complicated urinary tract infections, bone and joint infections, and some intra-abdominal infections. Doctors weigh the benefits against the risks for each individual patient before prescribing them.
Common Fluoroquinolones You May Encounter
- Ciprofloxacin (Cipro): One of the oldest and most widely used, often prescribed for urinary tract and gastrointestinal infections.
- Levofloxacin (Levaquin): Frequently used for respiratory infections and pneumonia.
- Moxifloxacin (Avelox): Often chosen for respiratory tract infections and certain skin infections.
- Delafloxacin (Baxdela): A newer option used for acute skin infections and community-acquired pneumonia.
Side Effects and Safety Concerns
Most people who take a fluoroquinolone complete their course without serious problems. Common side effects include nausea, diarrhea, dizziness, and headache. The more concerning risks, while uncommon, can be severe and in some cases long-lasting.
Tendon Damage
Fluoroquinolones can weaken tendons, particularly the Achilles tendon. A large study of over one million Medicare beneficiaries found that levofloxacin was associated with a 120% increased risk of Achilles tendon rupture within 30 days of use. The risk is higher in adults over 60, people taking corticosteroids, and those with kidney, heart, or lung transplants. Pain, swelling, or stiffness in a tendon during or shortly after treatment is a signal to stop the medication and contact your prescriber.
Nerve Problems
These drugs can cause peripheral neuropathy, a type of nerve damage that produces tingling, numbness, burning, or pain, typically in the hands and feet. This can begin within days of starting the medication and may persist after stopping it. The FDA’s boxed warning specifically notes that nerve damage from fluoroquinolones can be permanent.
Central Nervous System and Psychiatric Effects
Fluoroquinolones can stimulate the central nervous system, leading to restlessness, lightheadedness, confusion, tremor, and in rare cases hallucinations or seizures. Psychiatric reactions including anxiety, depression, and confusion have also been reported. These reactions can occur after just the first dose. Australia’s drug safety agency found that the most frequently reported serious psychiatric events for this drug class were confusion, anxiety, and depression.
Muscle and Joint Effects
Beyond tendons, fluoroquinolones can cause muscle weakness, joint pain, and joint swelling. The FDA warning groups these musculoskeletal effects together with the tendon and nerve risks because they can occur simultaneously in the same patient.
Who Should Avoid Them
Fluoroquinolones are generally contraindicated in children under 18 because studies in young animals showed cartilage damage in weight-bearing joints. Major regulatory agencies in the US, Europe, UK, Australia, and New Zealand all restrict pediatric use for most conditions.
Older adults face higher risk for tendon rupture and nerve-related side effects. People with a history of tendon disorders, those already taking corticosteroids, and anyone with myasthenia gravis (a neuromuscular condition) are also at elevated risk. If you’ve had a bad reaction to any fluoroquinolone in the past, the entire class is typically off-limits.
Mineral Interactions and Timing
One practical detail that catches many people off guard: fluoroquinolones bind to minerals like calcium, magnesium, iron, zinc, and aluminum in your digestive tract. When this happens, your body absorbs far less of the antibiotic, which can make it ineffective. This means you need to separate your doses from antacids, multivitamins, iron supplements, and even some dairy products.
The exact timing varies by drug. Ciprofloxacin and delafloxacin should be taken at least 2 hours before or 6 hours after any of these products. Levofloxacin requires at least a 2-hour gap in either direction. Moxifloxacin needs the widest window: at least 4 hours before or 8 hours after. If you’re taking a fluoroquinolone, check whether any of your other supplements or medications contain these minerals.
Growing Resistance
Widespread use of fluoroquinolones has driven increasing bacterial resistance. Bacteria develop resistance primarily through two routes. First, they accumulate mutations in the genes encoding the very enzymes fluoroquinolones target. These mutations change the shape of the enzyme’s binding site so the drug can no longer latch on effectively. In some species like Staphylococcus aureus and Pseudomonas aeruginosa, a single mutation is enough to produce meaningful resistance. In others like E. coli and gonorrhea, multiple mutations are needed, but resistance has still emerged over time.
The second route involves the bacteria changing how much drug gets inside the cell. Some bacteria reduce the number of channels in their outer membrane that the drug passes through. Others ramp up efflux pumps, molecular machinery that actively pushes the antibiotic back out before it can do its job. In many resistant bacteria, both mechanisms operate together, compounding the problem. This is one reason public health agencies now push to limit fluoroquinolone prescribing to situations where they’re truly necessary.